EXHIBIT 99.1
JOINT FILING AGREEMENT
The undersigned hereby agree that the Statement on Schedule 13G filed herewith (and any amendments thereto), relating to the Shares of Terns Pharmaceuticals, Inc., a Delaware corporation, is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, as amended, on behalf of each of the undersigned.
This Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument.
Dated July 22, 2024.
| CITADEL SECURITIES LLC | CITADEL ADVISORS LLC | |||
| By: | /s/ Guy Miller | By: | /s/ Seth Levy | |
| Guy Miller, Authorized Signatory | Seth Levy, Authorized Signatory | |||
| CITADEL SECURITIES GROUP LP | CITADEL ADVISORS HOLDINGS LP | |||
| By: | /s/ Guy Miller | By: | /s/ Seth Levy | |
| Guy Miller, Authorized Signatory | Seth Levy, Authorized Signatory | |||
| CITADEL SECURITIES GP LLC | CITADEL GP LLC | |||
| By: | /s/ Guy Miller | By: | /s/ Seth Levy | |
| Guy Miller, Authorized Signatory | Seth Levy, Authorized Signatory | |||
| KENNETH GRIFFIN | ||||
| By: | /s/ Seth Levy | |||
| Seth Levy, attorney-in-fact* | ||||
* Seth Levy is signing on behalf of Kenneth Griffin as attorney-in-fact pursuant to a power of attorney previously filed with the Securities and Exchange Commission, and hereby incorporated by reference herein. The power of attorney was filed as an attachment to a filing by Citadel Advisors LLC on Schedule 13G for Allakos Inc. on October 13, 2023.